PolyPid Ltd (POLY) - Product Pipeline Analysis, 2018 Update


PolyPid Ltd (PolyPid) is a pharmaceutical company that develops manufactures and commercializes therapies for the treatment of various medical conditions including infection, pain, inflammation and cancer. The company’s pipeline product candidates include D-Plex100, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX1000, a product candidate used in orthopedic surgeries for the prevention of surgical site infections and support of bone recovery; and D-PLEX500 for use in periodontal and oral or maxillofacial surgeries to treat peri-implantitis. It develops its products using polymer-lipid encapsulation matrix technology. The company collaborates with pharmaceutical and biotechnology companies through licensing and collaboration agreements for the encapsulation of their drugs including peptides, proteins and antibodies. PolyPid is headquartered in Petach Tikva, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company PolyPid Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

PolyPid Ltd Company Overview
PolyPid Ltd Company Snapshot
PolyPid Ltd Pipeline Products and Ongoing Clinical Trials Overview
PolyPid Ltd – Pipeline Analysis Overview
PolyPid Ltd - Key Facts
PolyPid Ltd - Major Products and Services
PolyPid Ltd Pipeline Products by Development Stage
PolyPid Ltd Ongoing Clinical Trials by Trial Status
PolyPid Ltd Pipeline Products Overview
BonyPid-1000 Product Overview
BonyPid-1000 Clinical Trial
BonyPid-500 Product Overview
BonyPid-500 Clinical Trial
D-PLEX Product Overview
D-PLEX Clinical Trial
PolyPid Ltd - Key Competitors
PolyPid Ltd - Key Employees
PolyPid Ltd - Key Employee Biographies
PolyPid Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
PolyPid Ltd, Recent Developments
Dec 21, 2017: PolyPid Appoints Jacob Harel as Chairman of the Board of Directors
Aug 16, 2017: PolyPid Completes Enrollment in Phase Ib/II Study of D-PLEX in Post-Cardiac Surgery Sternal Infection
Mar 09, 2017: PolyPid Announces Positive Interim Data from Company's Confirmatory Clinical Trial for BonyPid-1000 Antibiotic Eluting Bone Substitute
Mar 08, 2017: PolyPid Announces Receipt of Qualified Infectious Disease Product Designation from FDA for D-PLEX in Post-Cardiac Surgery Sternal Infection
Dec 02, 2015: PolyPid Announces First Patient Enrolled in Confirmatory Clinical Trial, Evaluating Performance and Safety of BonyPid-1000, an Antibiotic Eluting Bone Void Filler
Nov 19, 2015: PolyPid Announces Issuance of New U.S. Patent for Doxycycline Sustained Release Compositions
Jul 07, 2014: PolyPid Announces US Patent Allowance for Sustained Release of Nucleic Acid Matrix Compositions
Jun 18, 2014: PolyPid Wins First Prize at Biomed Startup Competition
Dec 10, 2012: PolyPid Announces Positive Preliminary Results Of Clinical Trial With BonyPid
Apr 23, 2012: PolyPid Joins Rimonim Consortium to Develop Delivery System for RNA-based Drugs
About GlobalData
Contact Us
List of Tables
PolyPid Ltd Pipeline Products and Ongoing Clinical Trials Overview
PolyPid Ltd Pipeline Products by Equipment Type
PolyPid Ltd Pipeline Products by Indication
PolyPid Ltd Ongoing Clinical Trials by Trial Status
PolyPid Ltd, Key Facts
PolyPid Ltd, Major Products and Services
PolyPid Ltd Number of Pipeline Products by Development Stage
PolyPid Ltd Pipeline Products Summary by Development Stage
PolyPid Ltd Ongoing Clinical Trials by Trial Status
PolyPid Ltd Ongoing Clinical Trials Summary
BonyPid-1000 - Product Status
BonyPid-1000 - Product Description
BonyPid-1000 - Safety and Performance of BonyPid-1000 in the Treatment of Gustilo I, II, IIIA and IIIB Tibial Open Fractures
BonyPid-500 - Product Status
BonyPid-500 - Product Description
BonyPid-500 - PolyPid, Ltd. Pilot Study of the BonyPid-500 Bone Graft Substitute
D-PLEX - Product Status
D-PLEX - Product Description
D-PLEX - A Phase Ib/II Prospective, Multicenter, Two Part Study; Part 1 - Open Label, Single Arm and Part 2 Randomized, Single-blinded (Study to Assess Safety and Efficacy of D-PLEX Concomitantly with Standard of Care Versus Standard of Care Alone in the Prevention of Primary Sternal Infection Post Cardiac Surgery
PolyPid Ltd, Key Employees
PolyPid Ltd, Key Employee Biographies
PolyPid Ltd, Subsidiaries
List of Figures
PolyPid Ltd Pipeline Products by Equipment Type
PolyPid Ltd Pipeline Products by Development Stage
PolyPid Ltd Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook